Programa - ITRIBiS

PROGRAM
RECEPTION:
Introduction to
technology
transfer at IBIS
09:00 9:00 -10:00 h
09:30 10:00 10:30 11:00 PARALLEL
SESSIONS
INVESTORS’
FORUM
CDTI FINANCE
COUNSELING
PARTNERING
SESSION 1
10:00-11:30 h
10:00-11:30 h
COFFEE-BREAK
11:30 12:00 SESSION 2
12:30 12:00-13:00 h
13:00 13:30 SESSION 3
14:00 13:30-14:30 h
12:00-14:30 h
14:30 12:00-14:30 h
12:00-14:30 h
15:30-17:30 h
15:30-17:30 h
LUNCH
15:00 15:30 16:00 16:30 17:00 17:30 If you are interested in attending and/or participating in any of
the activities, please register in the application available in the
ITRIBIS web site http://www.itribis.ibis-sevilla.es/events/.
Throughout the inscription process, you may choose between
the forms of participation in which you are more interested.
Download Program
If you wish to receive further information about any of the
activities, please send an email to [email protected] and
we will contact you.
RECEPTION:
Mr. Ramón González Carvajal. General Secretary of Research, Development and Innovation.
Consejería de Salud. Junta de Andalucía
Mr. Javier Montero Plata. Director of the Technology Transfer Office of the Andalusian Public
Health System
INTRODUCTION
TO TECHNOLOGY Mr. Juan Martínez Armesto. Spanish National Research Council (CSIC), Deputy Vicepresidency
TRANSFER AT IBIS for Knowledge Transfer, IPR Specialist
(9:00-10:00 H)
Mr. Miguel Torres García. Director of the Knowledge Transfer and Entrepreneurship Secretary,
Universidad de Sevilla
Mr. José Cañón Campos. Managing Director of the Instituto de Biomedicina de Sevilla (IBIS)
PARALLEL SESSIONS
SESSION 1
PRIVATE
INVESTMENT IN
BIOMEDICINE
Moderator: Mr. Javier Montero Plata. Director of the Technology Transfer Office of the
Andalusian Public Health System
Mrs. María Luisa García. Entrepreneurs Vice President of AABAN (Asociación Andaluza Business
Angels Networks)
Mr. Martín Rivas Antón. General Director of UNINVEST
Mr. Carlos Lora Calvo. Co-founder of ESPACIO-RES
(10:00-11:30 H)
Mr. Enrique Sainz Martínez. CEO CANAAN RESEARCH & INVESTMENT
SESSION 2
Moderator: Mrs. Luzma García Piqueres. Technology Transfer Manager at Centro de
investigación Biomédica en Red - CIBER
KEY ASPECTS IN
TECHNOLOGY
TRANSFER AND
BUSINESS
DEVELOPMENT IN
BIOMEDICINE
(12:00-13:00 H)
SESSION 3
Mr. Lucas Martínez Clar. Partner CEO DCN
Mr. Jörg Landwehr. Managing Partner ACTEA VENTURES
Mr. Gustavo Fúster Olaguibel. Managing Director of Spanish Office. HOFFMANN EITLE
Mr. Matías Garrido Cortés. Senior Associate. GARRIGUES
Mr. Diego Velasco Escribano. Head of Innovation. INSTITUTO RAMÓN Y CAJAL DE INVESTIGACIÓN
SANITARIA
Moderator: Mrs. Berta Rodríguez Campins. R&D & Administration Department Manager.
NEWBIOTECHNIC SA
Mr. Samuel Borreguero. Business Development Director. TALEMNOLOGY
SUCCESSFUL
CASES OF PUBLICPRIVATE
COOPERATION IN
IBIS
Mr. Manuel Romero Gómez. HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO- VIRGEN MACARENA
(13:30-14:30 H)
Mr. Manuel Sanz Vázquez. CEO. ONCOMATRYX
Mr. Enrique de Álava Casado. Head of Anatomical Pathology. HOSPITAL UNIVERSITARIO
VIRGEN DEL ROCÍO- VIRGEN MACARENA
INVESTORS’ FORUM
(12:00-14:30 H)
Mr. Francisco Rebollo Alcalá. ECM Product Manager. Division Digital business Application &
Customer Experience. IECISA
Mr. Carlos Parra Calderón. Head of Technological Innovation Unit. HOSPITAL UNIVERSITARIO
VIRGEN DEL ROCÍO- VIRGEN MACARENA
PARTICIPATING COMPANIES: DIGITÁLICA HEALTH, VAXDYN, DRUGID BIOTECH,
TALEMNOLOGY, ANKAR FARMA, ONCOMATRYX, PRONACERA NEURON BIO, CELLULIS
(AND OTHERS)
MAPS OF INSTITUTO DE BIOMEDICINA DE SEVILLA (IBIS)